Abstract
We report the synthesis and SAR of a series of novel azaindole CB(2) agonists. 6-Azaindole 18 showed activity in an acute pain model but was inactive in a chronic model. 18 is a Pgp substrate with low brain penetration. The template was redesigned, and the resulting 5-azaindole 36 was a potent CB(2) agonist with high CNS penetration. This compound was efficacious in the acute model and the chronic joint pain model.
MeSH terms
-
Aminopyridines / pharmacokinetics
-
Aminopyridines / therapeutic use*
-
Animals
-
Aza Compounds
-
Brain / metabolism*
-
CHO Cells
-
Cell Line
-
Chronic Disease
-
Cricetinae
-
Cricetulus
-
Drug Discovery
-
Humans
-
Indoles
-
Morpholines / pharmacokinetics
-
Morpholines / therapeutic use*
-
Pain / drug therapy*
-
Rats
-
Receptor, Cannabinoid, CB2 / agonists*
-
Structure-Activity Relationship
Substances
-
1-(4-(3-chlorophenylamino)-1-methyl-1H-pyrrolo(3,2-c)pyridin-7-yl)-1-morpholin-4-ylmethanone
-
5-azaindole
-
Aminopyridines
-
Aza Compounds
-
Indoles
-
Morpholines
-
Receptor, Cannabinoid, CB2